PDS Biotechnology Corp Total Liabilities and Equity
PDS Biotechnology Corp (PDSB) had Total Liabilities and Equity of $8.81 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-13
- 2026-06-30: Liabilities and Equity $8.81M.
- 2026-03-31: Liabilities and Equity $24.66M.
- 2025-12-31: Liabilities and Equity $30.49M.
- 2025-09-30: Liabilities and Equity $34.71M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $8.81M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $24.66M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $30.49M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $34.71M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $40.48M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $47.03M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $45.36M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $52.45M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $60.50M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $69.01M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $59.39M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $57.19M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $63.75M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $68.45M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $77.01M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $74.89M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $56.00M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $61.04M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $67.20M 10-K · filed 2023-03-28 | |
| 2021-09-30 | $71.75M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $77.39M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $27.76M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $30.89M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $34.45M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $20.09M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $23.93M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $14.49M 10-K · filed 2021-03-18 | |
| 2019-09-30 | $19.38M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $25.80M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $31.05M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $164.43K 10-K · filed 2020-03-27 | $36.22M 10-K · filed 2019-02-21 |
| 2018-09-30 | $37.67M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $47.21M 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $76.61M 10-Q · filed 2018-05-01 | |
| 2017-12-31 | $92.62M 10-K · filed 2019-02-21 | |
| 2017-09-30 | $101.24M 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $112.99M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $99.90M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $110.91M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $116.58M 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $115.42M 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $123.77M 10-Q · filed 2016-05-03 | |
| 2015-12-31 | $134.09M 10-K · filed 2017-03-02 | |
| 2015-09-30 | $58.48M 10-Q · filed 2015-11-06 | |
| 2014-12-31 | $16.85M 10-K · filed 2016-03-08 | $17.05M 10-Q · filed 2015-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |